LONDON--(BUSINESS WIRE)--
FORM 8.3
Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 02 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,877,218 |
1.46% |
383,944 |
0.30% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
153,127 |
0.12% |
69,804 |
0.05% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
(4) |
TOTAL: |
|
|
|
|
2,036,445 |
1.58% |
459,848 |
0.36% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 2 |
227.1800 USD |
Purchase | 5 |
225.5100 USD |
Purchase | 10 |
226.7200 USD |
Purchase | 38 |
227.3200 USD |
Purchase | 70 |
225.9000 USD |
Purchase | 100 |
226.0950 USD |
Purchase | 100 |
226.3100 USD |
Purchase | 107 |
226.3456 USD |
Purchase | 109 |
226.1566 USD |
Purchase | 200 |
225.9140 USD |
Purchase | 200 |
227.2900 USD |
Purchase | 291 |
227.2590 USD |
Purchase | 300 |
226.8099 USD |
Purchase | 469 |
228.2935 USD |
Purchase | 597 |
227.9842 USD |
Purchase | 700 |
226.8371 USD |
Purchase | 717 |
228.0148 USD |
Purchase | 1,085 |
227.7066 USD |
Purchase | 1,151 |
227.1099 USD |
Purchase | 1,217 |
227.3129 USD |
Purchase | 1,622 |
227.4403 USD |
Purchase | 1,790 |
227.6563 USD |
Purchase | 2,021 |
227.5768 USD |
Purchase | 3,352 |
226.1913 USD |
Purchase | 5,497 |
227.1100 USD |
Purchase | 8,221 |
227.5494 USD |
Purchase | 12,465 |
227.4397 USD |
Purchase | 24,455 |
227.2374 USD |
Purchase | 26,898 |
227.2053 USD |
Sale | 5 |
225.5100 USD |
Sale | 43 |
225.9900 USD |
Sale | 45 |
227.6200 USD |
Sale | 47 |
225.8923 USD |
Sale | 50 |
226.9100 USD |
Sale | 53 |
228.2100 USD |
Sale | 78 |
226.4800 USD |
Sale | 100 |
225.8700 USD |
Sale | 100 |
225.8550 USD |
Sale | 100 |
228.7200 USD |
Sale | 100 |
225.5500 USD |
Sale | 100 |
228.3250 USD |
Sale | 100 |
227.2000 USD |
Sale | 220 |
225.3481 USD |
Sale | 234 |
228.0085 USD |
Sale | 270 |
226.1241 USD |
Sale | 284 |
228.2833 USD |
Sale | 340 |
227.4885 USD |
Sale | 397 |
227.6178 USD |
Sale | 546 |
227.2433 USD |
Sale | 575 |
227.3473 USD |
Sale | 614 |
226.6143 USD |
Sale | 755 |
227.4005 USD |
Sale | 757 |
227.0385 USD |
Sale | 882 |
226.5347 USD |
Sale | 1,117 |
227.1464 USD |
Sale | 1,151 |
227.1099 USD |
Sale | 1,294 |
227.5252 USD |
Sale | 1,315 |
227.6895 USD |
Sale | 1,376 |
227.3200 USD |
Sale | 1,627 |
227.8643 USD |
Sale | 1,679 |
227.4234 USD |
Sale | 2,487 |
227.1100 USD |
Sale | 2,537 |
227.1470 USD |
Sale | 4,863 |
226.7868 USD |
Sale | 5,937 |
227.5038 USD |
Sale | 6,285 |
226.9142 USD |
Sale | 6,908 |
227.5103 USD |
Sale | 7,540 |
227.3732 USD |
Sale | 9,711 |
227.3891 USD |
Sale | 30,854 |
227.2544 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 4 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or |
Number of |
Exercise |
Type |
Expiry |
purchased |
relevant securities |
price |
|
date |
|
|
to which the option |
|
|
|
|
|
or derivative |
|
|
|
|
|
relates |
|
|
|
|
Put Options | Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options | Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.